Contezolid for the Treatment of Drug-Resistant Tuberculosis in China: A Clinical Case Series
These case studies suggest that CZD could represent an effective and safe option for anti-TB therapy, especially for patients intolerant to LZD.
Authors
- Ya-Xue Liang
- Lei Xie (ORCID: https://orcid.org/0000-0002-6691-2294)
- Lei Gao (ORCID: https://orcid.org/0000-0001-9030-390X)
- Pengfei Huang (ORCID: https://orcid.org/0000-0001-5602-1730)
- Yifan Han (ORCID: https://orcid.org/0000-0002-5833-069X)
- Shuang Liu (ORCID: https://orcid.org/0000-0002-8495-5562)
- Yan-Jun Xiong
- Yu Xiao
- Hua Wang (ORCID: https://orcid.org/0000-0002-7319-6249)
Institutions
- Anhui Provincial Hospital (CN)
Publication Details
- Journal
- Infection and Drug Resistance
- Published
- 2024-08-01
- DOI
- https://doi.org/10.2147/idr.s469509
- Citations
- 8
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 3.11